| Stage | CNP | % of rev | ETR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $3.5B | 100.00% | ETR ×1.61 |
| Gross profit | $1.3B | 57.33% | $2.5B | 69.73% | ETR +12.4pp |
| Operating income | $667M | 30.44% | $850M | 24.13% | CNP +6.3pp |
| Pre-tax income | $413M | 18.85% | $619M | 17.58% | CNP +1.3pp |
| Net income | $331M | 15.11% | $488M | 13.84% | CNP +1.3pp |
| Stage | CNP | ETR | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $3.5B100.00% | ETR ×1.61 |
| Gross profit | 57.33%$1.3B | 69.73%$2.5B | ETR +12.4pp |
| Operating income | 30.44%$667M | 24.13%$850M | CNP +6.3pp |
| Pre-tax income | 18.85%$413M | 17.58%$619M | CNP +1.3pp |
| Net income |
| 15.11%$331M |
| 13.84%$488M |
| CNP +1.3pp |
No shared counterparties.